1. Volume 77, Issue 9, Pages 809-815 (May 2010)
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 
Camillo Porta, Chiara Paglino, Mara De Amici, Silvana Quaglini, Lucia Sacchi, Ilaria Imarisio, Cinzia Canipari 
Kidney International 
Volume 77, Issue 9, Pages (May 2010)
DOI: /ki
Copyright © 2010 International Society of Nephrology Terms and Conditions

2. Figure 1
Survival curves of patients with favorable (=0) or intermediate (=1) Motzer score. Although different up to about 1 year, the two groups come to a similar prognosis, the resulting overall difference being not significant.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions

3. Figure 2
VEGF value distribution and relationship to PFS. (a) Histogram showing vascular endothelial growth factor (VEGF) value distribution. (b) Survival curves of patients with VEGF values below and above the threshold.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions

4. Figure 3
NGAL value distribution and relationship to PFS. (a) Histogram showing neutrophil gelatinase-associated lipocalin (NGAL) value distribution. (b) Survival curves of patients with NGAL values below and above the threshold.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions

5. Figure 4
Survival curves of patients with both vascular endothelial growth factor (VEGF) and neutrophil gelatinase-associated lipocalin (NGAL) titers below the threshold, with both VEGF and NGAL titers above the threshold, and with either value above the threshold and the other one below.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions